Trial intelligence / Profile preview

Non-operative amoxicillin/clavulanic acid vs surgery in pediatric uncomplicated appendicitis

2024-519402-12-00Phase 3Authorised

Sponsor
Centre hospitalier universitaire de Toulouse
Start
Oct 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of amoxicillin + clavulanate in acute appendicitis (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Treatment-related failure rate at one year. Planned start Oct 2025; status: authorised.

02

Drugs

amoxicillin + clavulanate
03

Conditions

acute appendicitis

Beyond the preview

Go deeper on 2024-519402-12-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-519402-12-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call